Freyr Solutions

Freyr Solutions added blog Health
2026-05-20 08:13:25 -

NDA vs BLA: FDA Drug Approval Pathways Explained
Bringing a new therapy to market in the United States is a highly complex process that requires careful scientific, regulatory, and commercial planning. One of the most important early decisions in drug development is determining whether a product should follow the New Drug Application (NDA) pathway or the Biologics License Application (BLA) pathway. While the distinction may appear...

0 Comments 0 Shares 3 Views 0 Reviews

Please log in to like, share and comment!
Freyr Solutions added blog Health
2026-05-20 08:11:51 -

Regulatory Strategy in Drug Development?
A promising molecule alone is not enough to ensure a successful drug development program. What often distinguishes therapies that successfully reach patients from those delayed by regulatory hurdles is the presence of a strong and well-executed regulatory strategy. Despite this, many sponsors—particularly emerging biotech companies and early-stage developers—still approach...

0 Comments 0 Shares 20 Views 0 Reviews

Please log in to like, share and comment!
Freyr Solutions added blog Health
2026-05-19 06:48:20 -

Pharmaceutical Industry in Nigeria
Nigeria’s pharmaceutical industry offers significant growth opportunities for global manufacturers and life sciences companies. However, entering the market requires navigating a complex regulatory framework, evolving compliance requirements, and operational challenges. Companies that succeed in Nigeria typically combine strong regulatory planning with local expertise, compliant...

0 Comments 0 Shares 25 Views 0 Reviews

Please log in to like, share and comment!
Freyr Solutions added blog Health
2026-05-19 06:46:43 -

Japan Pharma Market: Regulatory Localization Wins
Japan remains one of the world’s most attractive pharmaceutical markets, offering significant commercial opportunities for global life sciences companies. However, entering this market requires more than global regulatory approvals—it demands a well-planned localization strategy aligned with the expectations of Japan’s Pharmaceuticals and Medical Devices...

0 Comments 0 Shares 26 Views 0 Reviews

Please log in to like, share and comment!
Freyr Solutions added blog Health
2026-05-18 05:19:54 -

Managing Dynamic Digital Label Content Across Multiple Markets
In today’s pharmaceutical industry, labeling is no longer a static document updated only at scheduled intervals. It has evolved into a dynamic and continuously changing source of information that must reflect the latest safety findings, regulatory requirements, and scientific advancements. Managing digital label content across multiple global markets creates both opportunities and...

0 Comments 0 Shares 66 Views 0 Reviews

Please log in to like, share and comment!
Freyr Solutions added blog Health
2026-05-18 04:58:10 -

Company Core Data Sheet and Its Significance in the Pharma
The pharmaceutical industry operates in an increasingly complex and highly regulated global environment, where products are developed, approved, and marketed across multiple regions. Ensuring consistency in product information across these markets can be challenging. This is where the Company Core Data Sheet (CCDS) plays a vital role. Acting as a global reference document, the CCDS consolidates...

0 Comments 0 Shares 63 Views 0 Reviews

Please log in to like, share and comment!
Freyr Solutions added blog Health
2026-05-15 02:45:02 -

Regulatory Publishing and Submissions in 2026
Regulatory Publishing and Submissions in 2026: From Operational Support to Strategic Advantage Regulatory publishing and submissions are experiencing a significant transformation. What was once viewed primarily as a technical, execution-driven activity has now become a critical element of broader regulatory strategy. As submission volumes grow and global regulatory submissions...

0 Comments 0 Shares 151 Views 0 Reviews

Please log in to like, share and comment!
Freyr Solutions added blog Health
2026-05-15 02:00:04 -

Scaling Regulatory Submissions Across North America and Europe
Scaling Regulatory Submissions Across North America and Europe As pharmaceutical companies expand globally, scaling regulatory submissions across North America and Europe has become more than a compliance requirement — it is now a strategic business priority. Managing global regulatory submissions across multiple regions involves increasing complexity due to varying regulatory frameworks,...

0 Comments 0 Shares 186 Views 0 Reviews

Please log in to like, share and comment!
Freyr Solutions added blog Health
2026-05-15 01:50:35 -

Transitioning to Proactive and Data-Driven Safety Management
Pharmacovigilance in 2026: A Shift Toward Proactive Drug Safety Pharmacovigilance (PV) in 2026 is undergoing a major transformation. Growing data volumes, rapid technological advancements, and increasing regulatory expectations are redefining how organizations approach drug safety management. Traditional PV models focused mainly on compliance and adverse event reporting are evolving into more...

0 Comments 0 Shares 200 Views 0 Reviews

Please log in to like, share and comment!
Freyr Solutions added blog Health
2026-05-13 09:49:03 -

Philippines Pharmaceutical Market Entry 2026
Malaysia Pharmaceutical Regulations 2026: Key NPRA Updates and Market Entry Considerations Manufacturers planning pharmaceutical market entry into Malaysia in 2026 must prepare for a series of important regulatory reforms introduced by the National Pharmaceutical Regulatory Agency (NPRA). Effective from 2025 onward, these updates will significantly impact product registration, pharmacovigilance...

0 Comments 0 Shares 103 Views 0 Reviews

Please log in to like, share and comment!
Freyr Solutions added blog Health
2026-05-13 09:47:14 -

Philippines Pharmaceutical Market Entry 2026
Major Regulatory Updates Shaping Market Entry in 2026 1. Revised Product Registration Framework Administrative Order (AO) No. 2024-0013, effective in 2025, significantly updates the registration process for pharmaceutical products and active pharmaceutical ingredients (APIs) intended for human use. The revised framework: Aligns submissions with ASEAN Common Technical Dossier (ACTD) and CTD...

0 Comments 0 Shares 81 Views 0 Reviews

Please log in to like, share and comment!
Freyr Solutions added blog Health
2026-05-13 04:15:45 -

ARTG Inclusion in Australia
Navigating ARTG Inclusion: Building a Smarter Regulatory Strategy for Australia Freyr supports pharmaceutical companies in navigating Australia’s highly regulated and commercially significant healthcare market. As regulatory expectations continue to evolve, gaining inclusion in the Australian Register of Therapeutic Goods (ARTG) has become more than a procedural requirement—it is...

0 Comments 0 Shares 114 Views 0 Reviews

Please log in to like, share and comment!